Multidisciplinary care is a cornerstone of modern management for high- and very-high-risk cutaneous squamous cell carcinoma ...
Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...
Imaging is more sensitive than physical examination for nodal staging of cutaneous squamous cell carcinoma, according to a ...
Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more ...
Switching to sirolimus significantly reduces the risk of subsequent cSCC in high-risk kidney transplant recipients with history of the skin cancer. Switching kidney transplant recipients (KTRs) with ...
Findings showed cemiplimab reduced the risk of disease recurrence or death by 68% compared with placebo. The Food and Drug Administration (FDA) has approved Libtayo ® (cemiplimab-rwlc) for the ...
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, arising from abnormal proliferation of epidermal keratinocytes due to chronic UV exposure. While highly curable (>90%) ...
COLUMBUS, Ohio (WCMH) — Columbus State Community College officially broke ground Friday on its OhioHealth Hall. The new academic building will help graduates enter in-demand fields while modernizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results